At the news
? NEUTRALIMPACT 2/10 DEFA14A filed Mar 12, 2026 at 08:32 ET
Analysis based on filing metadata only, document content was unavailable
- Filing is a DEFA14A (Definitive Additional Materials) for West Pharmaceutical Services, Inc.
- It is a proxy statement for the 2026 Annual Meeting.
- The meeting will be held virtually on May 4, 2026.
- Proposals include the election of 11 directors, an advisory vote on executive compensation, ratification of the independent auditor, and a shareholder proposal on an independent board chair.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access